Cancer Immunotherapy Market to touch US$ 145 Billion By 2022
New York, August 11, 2018: The cancer immunotherapy market is segmented on the lines of its type, application, end user and regional. Based on type segmentation it covers immunomodulators, checkpoint inhibitors, cancer vaccines and monoclonal antibodies. Under application segmentation it covers melanoma, colorectal cancer, prostate cancer, head and neck cancer, breast cancer and lung cancer. The cancer immunotherapy market is segmented on the lines of its end user like clinics and others hospitals. The cancer immunotherapy market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. Immunotherapy is a treatment which uses particular parts of person’s immune organism to fight against cancer. Immune system is a collection of s...